Concordia launches $4.3bn of loans for AMCo purchase
Concordia Healthcare, the Canadian drug company, has agreed new credit facilities and bridging commitments of up to $4.3bn to pay for the acquisition of Amdipharm Mercury from Cinven.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: